Skip to Content
JGGJournal of Gerontology and Geriatrics
  • Article
  • Open Access

21 November 2026

20 Pages

Development of a Combined Blood Flow Restriction and Aerobic Exercise Programme in Older Adults with Sarcopenia: A Delphi Study

,
,
,
,
,
,
and
1
School of Nursing, Suzhou Vocational Health College, Suzhou 215009, China
2
Age-Wise Care (Suzhou) Intelligent Technology Co., Ltd., Suzhou 215000, China
3
Department of Orthopedics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou 215000, China
4
Gusu School, Nanjing Medical University, Suzhou 215000, China
J. Gerontol. Geriatr.2026, 74(4), 47;https://doi.org/10.3390/jgg74040047 
(registering DOI)
This article belongs to the Topic Healthy, Safe and Active Aging, 3rd Edition

Abstract

Blood flow restriction (BFR) training can produce benefits similar to those of moderate-intensity exercise even at low intensity, which makes it especially relevant for older adults with sarcopenia and limited exercise capacity. This study aimed to develop a combined BFR and aerobic exercise (BFR-AE) programme for this population. An evidence-informed narrative review and our team’s earlier exploratory work informed the first draft. In the exploratory work, 120 nursing-home residents aged 60 years or older were screened, 40 met the eligibility criteria, 33 were enrolled after giving informed consent, and 31 completed all 11 exercise tests (mean age 84.81 ± 6.19 years). Two rounds of Delphi consultation were then conducted from February to March 2023 with 12 specialists in exercise science, rehabilitation, and nursing. All 12 experts responded in round 1 (100%) and 11 in round 2 (91.7%). Authority coefficients were 0.91 and 0.94. Kendall’s W increased from 0.088 to 0.310, which represents a statistically significant but moderate level of concordance. Coefficients of variation for perceived methodological appropriateness (scientificness) decreased from 0.28–0.38 to 0.06–0.18 and for feasibility from 0.26–0.37 to 0.06–0.18. The final programme has content validity and expert-perceived feasibility, and it provides a structured protocol for future trials. Its parameters rest on three kinds of support: prior empirical evidence, our own exploratory data, and expert consensus where the evidence was insufficient. Expert consensus establishes content validity and perceived feasibility only; it does not demonstrate clinical efficacy, dose–response optimisation, or definitive safety, which require adequately powered randomised controlled trials.

1. Introduction

Sarcopenia is a geriatric syndrome characterised by progressive, age-related loss of skeletal muscle mass throughout the body, accompanied by a decline in muscle strength and/or physical function [1,2]. Approximately 50 million older adults worldwide currently have sarcopenia, and this number is projected to reach 500 million by 2050 [3]. China has the world’s largest older population, and sarcopenia is set to become one of the major burdens on its healthcare system. Many older adults with sarcopenia experience declines in muscular fitness (MF) and cardiorespiratory fitness (CF), which leads to reduced physical activity. This, in turn, contributes to falls, fractures and disability, increases hospitalisation and mortality, and adds to the burden borne by healthcare systems and families. No drug is currently licensed to treat sarcopenia, and exercise remains the main intervention, whether resistance exercise (RE) or aerobic exercise (AE) [2]. RE improves muscular fitness and functional capacity in older adults with sarcopenia, whereas AE improves cardiorespiratory fitness. The American College of Sports Medicine (ACSM) and the American Heart Association (AHA) jointly recommend that frail older adults or those with no history of exercise begin with low-intensity AE and add RE once their fitness has improved [4]. In practice, however, their low fitness limits both exercise capacity and participation.
Blood flow restriction training (BFRT) uses a compression device to apply external pressure to the limbs during exercise, restricting arterial blood flow to the working muscles so that the effects normally associated with high-intensity training are obtained at a low exercise intensity [5,6]. In athletes, BFRT increases muscle cross-sectional area, muscular fitness, and aerobic capacity [7]. Staunton et al. compared haemodynamic responses in older adults during BFR combined with resistance exercise (BFR-RE) and with aerobic exercise (BFR-AE): responses were higher during BFRT than during exercise without BFR but lower in the BFR-AE condition than in the BFR-RE condition [8]. Several studies have found that adding BFR to even low-intensity AE produces greater hypertrophy and strength gains than the same exercise performed without BFR [9,10,11]. BFR-AE may therefore suit older adults with sarcopenia, but agreed standards for the exercise and BFR variables are still lacking.
In previous studies, BFR-RE has been the combination most often studied [12]. For older adults with poor physical fitness and no exercise habits, however, the usual advice is to start with AE and to add RE gradually once they have adapted [13]. Simpler and more readily delivered alternatives are therefore needed for this population.
Therefore, building on previous studies that preliminarily established the key intervention elements of BFR-AE [14], this study used the Delphi method to develop a BFR-AE programme for older adults with sarcopenia. This paper reports the protocol-development phase of a larger project. The programme developed here is the intervention subsequently tested in our registered randomised controlled trial (ChiCTR2200064080) and described in the published trial protocol [15]; this paper describes how the intervention was developed, not what it does. The observations reported here therefore belong to protocol development, and the results of that trial should not be read as retrospective validation of the protocol presented here. Our working hypothesis is that adding BFR to aerobic exercise at an equivalent external workload augments the training stimulus at a lower absolute intensity; the present study does not test this hypothesis and provides no evidence of an additive effect of BFR.

2. Materials and Methods

2.1. Development of a Preliminary Draft of the BFR-AE Intervention Programme for Older Adults with Sarcopenia

2.1.1. Literature Review

The research team conducted an evidence-informed narrative literature review in CNKI, Wanfang, CQVIP, PubMed, MEDLINE, Web of Science, and the Cochrane Library from database inception to May 2022. The search combined the following terms: (“blood flow restriction” OR “blood flow restriction training” OR “KAATSU” OR “occlusion training”) AND (“sarcopenia” OR “sarcopenic” OR “older adults” OR “aged”) AND (“aerobic exercise” OR “walking” OR “cycling” OR “bicycle” OR “stepping”). Searches were limited to title and keyword fields and to English or Chinese publications. Two researchers independently screened titles/abstracts and full texts. Inclusion criteria were (1) older adults with sarcopenia or at risk of sarcopenia; (2) BFR combined with aerobic exercise or BFR alone with aerobic-type exercise; (3) reported exercise variables (mode, intensity, duration, frequency, and speed) or BFR variables (device, pressure, cuff placement, and inflation/deflation protocol); and (4) original studies, systematic reviews, or guidelines. Exclusion criteria were conference abstracts, non-peer-reviewed articles, non-human studies, and articles without available full text. Disagreements were resolved by a third researcher. Based on the retrieved literature and the exercise guidelines recommended by the ACSM and AHA [16], a general framework for BFR-AE interventions in older adults with sarcopenia was constructed, including exercise modality, intensity, duration, frequency, and speed. Unclear elements were also listed, including the selection of elastic versus non-elastic BFR devices, BFR pressure settings and safety, and exercise intensity and duration. Because this review was not designed or registered as a systematic review, formal counts of records retrieved, screened, assessed in full text, and included were not recorded, and no PRISMA flow diagram was produced; it is therefore reported as an evidence-informed narrative review rather than a systematic review. The complete search strings, field restrictions, language limits, and search date for each database are provided in Supplementary Table S2.

2.1.2. Exploratory Study to Identify Unresolved Factors in BFR-AE

From October 2022 to January 2023, we conducted exploratory exercise testing at a nursing home in Suzhou to identify the absolute exercise intensity (stepping resistance) that older adults with sarcopenia could sustain and to compare elastic and non-elastic BFR cuffs. Residents aged 60 years or older were screened for sarcopenia; of the 120 individuals screened, 40 met the eligibility criteria, 33 were enrolled after giving written informed consent, and 31 completed all 11 exercise tests (drop-out rate 6.1%). The 31 participants who completed all testing had a mean age of 84.81 ± 6.19 years and comprised 26 women and 5 men. The sample size was set at 33 so that at least 30 participants would complete the tests, allowing for an assumed attrition rate of 10%. In the first week, participants completed five sessions of seated stepping aerobic exercise without BFR (stepper: Jiujian Healthcare Co., Ltd., Kunshan, Suzhou, China; Model SCS1) on consecutive days in order to determine each individual’s absolute exercise intensity (stepping resistance). Based on the resistance established, BFR-AE tests with progressively increasing pressure were conducted with a non-elastic cuff (Yongling Medical Instrument Co., Ltd., Xiangtan, Hunan, Chian; 7.6 cm × 120 cm) and an elastic cuff (B strong Training Systems, Park City, UT, USA; 7.5 cm × 105 cm, size No. 3) to assess changes in cardiovascular variables before and after exercise, the occurrence of adverse events, and exercise completion. Eligible participants were aged 60–90 years, had independent mobility, had no regular exercise habit, and met the Asian Working Group for Sarcopenia 2019 (AWGS 2019) [2]. criteria for sarcopenia or probable sarcopenia AWGS 2019 defines low muscle strength as handgrip <28 kg in men and <18 kg in women; low physical performance as 6 m gait speed <1.0 m/s or 5-times sit-to-stand ≥12 s; and low appendicular skeletal muscle mass index (ASMI) as <7.0 kg/m2 in men and <5.7 kg/m2 in women. Sarcopenia required low muscle mass plus low strength or low performance; probable sarcopenia required low strength or low performance alone. Exclusion criteria were lower-limb surgery within 3 months or inability to walk at a normal pace; inability to perform grip testing; anticoagulant use, open soft-tissue injury or lymphoedema; uncontrolled hypertension (≥160/100 mmHg); acute or severe cardiovascular disease (acute myocardial infarction, acute heart failure, atrioventricular block, or recent coronary stent); lower-limb deep-vein thrombosis or atherosclerosis or lower-limb bone/joint or vascular surgery within 6 months; severe osteoporosis, coagulation disorders, pregnancy, sickle-cell anaemia, endothelial dysfunction, peripheral vascular disease, or a history of thrombotic or haemorrhagic stroke; and other standard exercise contraindications. All participants undertook all three conditions—aerobic exercise alone, non-elastic BFR, and elastic BFR—in a counterbalanced order (odd-numbered participants A → B → C; even-numbered participants A → C → B) to control for order effects; test sessions were separated by at least one day. Each exposure lasted 20 min, preceded and followed by a 3 min warm-up and cool-down. Blood pressure, pulse rate, and SpO2 were recorded before exercise, at 5 and 10 min during exercise, and 5 min after exercise, together with RPE and pain scores. General exercise responses were prespecified as participant-reported or investigator-observed lower-limb soreness or pain, dizziness, nausea, or any other intolerable discomfort; no serious adverse event occurred.
Exercise completion, general exercise responses, and adverse events were summarised descriptively. Blood pressure, pulse rate, and SpO2 measured at the four time points were analysed by repeated-measures analysis of variance, with the Greenhouse–Geisser correction applied when the sphericity assumption was violated, followed by simple-effects analysis; normality was checked with the Shapiro–Wilk test, and all tests were two-sided, with p < 0.05 considered statistically significant. In summary, completion was higher with the elastic device than with the non-elastic device at the two higher pressures (40% LOP: 100% vs. 87.1%; 60% LOP: 71.0% vs. 29.0%), and general exercise responses were less frequent (40% LOP: 22.6% vs. 45.2%; 60% LOP: 41.9% vs. 51.6%). Within each pressure level, blood pressure and pulse rate differed across measurement occasions (p < 0.05) but did not differ between pressure levels; compared with rest, the non-elastic device produced significant increases in systolic blood pressure, diastolic blood pressure, and pulse rate, whereas the elastic device produced significant increases only in systolic blood pressure and pulse rate. Pain scores after testing were 0 for both devices, the adverse event rate was 1.1%, and ratings of perceived exertion reached the moderate-intensity range in all tests. These findings, together with the haemodynamic comparison described in Section 2.1.3, determined the choice of the elastic device and of 250 mmHg as the upper bound of the pressure range; the complete results of this exploratory study are reported separately [17].
Combining the literature with our own findings, we drew up a preliminary draft of the BFR-AE programme for older adults with sarcopenia. It covers both the aerobic and the BFR component, specifying such implementation details as exercise duration, stepping resistance, and cuff pressure.

2.1.3. Safety Rationale for BFR Pressure Settings

The BFR pressure settings were selected on grounds of safety and feasibility. In our earlier work, elastic and non-elastic cuffs were compared in 31 older adults with sarcopenia who completed all exercise testing. Elastic cuffs do not completely occlude arterial blood flow, are generally better tolerated, and carry a lower risk of adverse cardiovascular responses; however, they cannot be used to measure limb occlusion pressure (LOP). Previous work from our group showed that a non-elastic cuff set at 40–60% LOP and an elastic cuff set at 150–250 mmHg produced comparable reductions in blood flow and that BFR combined with stepping aerobic exercise at 250 mmHg was safe and feasible in this population, with no serious adverse events. We therefore used an elastic cuff and a progressive pressure protocol: 150, 200, and 250 mmHg during the three adaptation sessions, followed by 250 mmHg during the formal intervention. Pressure was maintained throughout each exercise bout and released during the interval between bouts. The choice of the elastic cuff was made for this protocol and this population: within the conditions of the exploratory testing, the elastic cuff was better tolerated and achieved a higher completion rate at matched interface pressure. These observations do not establish the universal superiority of elastic over non-elastic BFR systems in older adults, and they should not be read as a general recommendation about device type.
The equivalence between the two cuffs was established in a separate haemodynamic study in 163 adults (mean age 51.05 ± 18.26 years), in which dorsalis pedis arterial blood flow was measured by Doppler ultrasound (Taike Medical Co., Ltd., Guangzhou, China; BV-520T) during compression with a non-elastic cuff at 40%, 50%, and 60% limb occlusion pressure (LOP) and with the elastic cuff at 150, 200, and 250 mmHg. In the sarcopenic subgroup, non-elastic compression at 40–60% LOP reduced arterial blood flow by 7.69–43.59%, whereas the elastic cuff at 150–250 mmHg reduced flow by 15.58–26.32%; the latter interval lies within the former. This is an indirect equivalence argument. The measurements were obtained under resting conditions, whereas the intervention is performed during exercise, so extrapolating to exercising muscle is approximate, and we make no stronger physiological claim. In the subsequent exercise testing, comparability between cuffs was operationalised by matching interface (contact) pressure: the elastic cuff was inflated to the pressure that reproduced the interface pressure recorded under the non-elastic cuff at 20%, 40%, and 60% LOP. Accordingly, 250 mmHg should be understood as the upper bound of the pressure range tested and tolerated with this specific elastic cuff in this specific population. It is not presented as an established optimal or universally transferable pressure, and it should not be applied to other devices or to unmonitored exercise. Because the pressure is fixed rather than individualised, it cannot accommodate the between-person variation in limb circumference and limb occlusion pressure that determines the actual reduction in arterial inflow, and that variation is likely to be at least as great in older adults with sarcopenia, in whom reduced muscle mass and altered limb composition change the pressure–flow relationship. What we observed is that 250 mmHg with this cuff was tolerated under supervised conditions and reduced resting blood flow to a degree lying within the range produced by 40–60% LOP with a non-elastic cuff; what we assumed—that the resting comparison extrapolates to exercising muscle and that a single fixed pressure is appropriate across individuals—remains untested. The value should therefore be read as a protocol-specific, pragmatic starting point rather than as an established optimal prescription.
The safety provisions fall into four groups. Absolute contraindications: These include acute or severe cardiovascular disease, lower-limb deep-vein thrombosis, uncontrolled hypertension, and other standard exercise contraindications as listed above. Relative contraindications: These include severe osteoporosis, anticoagulant therapy, peripheral vascular disease, and endothelial dysfunction, each requiring individual risk–benefit assessment. Monitoring thresholds: Heart rate, blood pressure, SpO2, RPE, and symptoms were assessed before exercise, at 5 and 10 min during exercise, and 5 min after exercise, with post-exercise blood lactate where indicated. Termination criteria: These are systolic blood pressure >200 mmHg or diastolic blood pressure >110 mmHg; a decrease in systolic blood pressure >10 mmHg relative to the pre-exercise baseline, assessed during exercise; SpO2 ≤80%; aggravated chest pain; asthma or dyspnoea; nausea, vomiting or dizziness; any other adverse reaction; or the participant’s request to stop. Criteria for medical referral: These comprise any termination event, any symptom persisting 5 min after exercise, or failure of blood pressure, pulse rate, and SpO2 to return to pre-exercise values; participants were not discharged until these values had recovered.
The safety provisions therefore operate at two levels. SpO2 ≤80% is the absolute termination threshold, set well below the level at which symptoms would be expected; a separate and earlier relative threshold—a fall of more than 5 percentage points from the individual pre-exercise baseline value or any desaturation accompanied by symptoms—triggers immediate evaluation and, where indicated, termination before the absolute threshold is reached. The relative criterion was added because an absolute threshold on its own can miss a clinically relevant fall in saturation in a participant whose baseline value is high. The absolute thresholds follow the indications for terminating an exercise test given in the American College of Sports Medicine guidelines [18] and the safety recommendations for blood flow restriction exercise [19]; blood pressure, pulse rate, and SpO2 were therefore measured at the fixed time points specified above rather than continuously, and the relative SpO2 criterion was added because an absolute threshold on its own would allow a clinically relevant fall in saturation to pass unrecognised in participants with a high baseline value. The same thresholds and the same distinction between absolute and relative criteria are applied in Intervention Program and in the trial protocol.

2.1.4. Expert Consultation

Experts were selected according to established Delphi principles [20,21,22,23]. The inclusion criteria were (1) a bachelor’s degree or higher; (2) at least 10 years of professional experience in nursing or rehabilitation, sport or medicine, including experience in designing exercise programs for older adults; (3) an intermediate or senior professional title; and (4) willingness to take part in the study. A panel of 10–50 experts is conventional for a Delphi exercise; our panel of 12 reflects both the narrow scope of the study—a single intervention protocol—and who was eligible and reachable. Experts were identified purposively through the corresponding authors of the studies retrieved in the literature review, the membership directories of the geriatric rehabilitation and sports medicine branches of the relevant professional associations, and institutional recommendation and were invited by e-mail; all those who met the inclusion criteria and accepted the invitation were enrolled. No incentive other than the honorarium declared in the funding statement was offered. The panel was deliberately drawn from both tertiary hospitals and universities and spanned sports training, exercise physiology, bone and joint rehabilitation, sports injury rehabilitation, nursing management, and physical activity and health promotion so that both clinical and academic perspectives were represented.
We then drew up a consultation questionnaire based on the preliminary draft. It had three sections. (1) The main body comprised two parts—the exercise programme and the settings for stepping resistance and BFR pressure—with 15 items in total. Each item was rated on a 5-point Likert scale on two dimensions. For perceived methodological appropriateness (scientificness), the scale points were “highly inappropriate, inappropriate, neutral, appropriate, and highly appropriate”; for feasibility, “highly unfeasible, unfeasible, neutral, feasible, and highly feasible”. Alongside the two rating scales of each item, an open-ended comment column invited suggestions for improvement. (2) A demographic questionnaire covered name, age, educational qualification, affiliated institution, professional title, and research domain. (3) An authority questionnaire asked about the experts’ familiarity with the consultation content and the basis for their judgements.
The Delphi process was conducted anonymously. In each round, experts received the questionnaire by email, rated each item on a 5-point Likert scale for perceived methodological appropriateness (scientificness) and feasibility, and provided open-ended comments. The response period was two weeks per round. After each round, the research team calculated mean scores, standard deviations, coefficients of variation (CVs), and Kendall’s W. The aggregated results and anonymised comments from round 1 were fed back to experts together with the round 2 questionnaire. Consensus was predefined as mean score > 3.5, CV < 0.25, and ≥80% of experts reporting no further revisions or supplementary opinions [24]. Items not meeting these criteria or receiving repeated concerns were discussed by the research team; revisions were made when supported by evidence and expert consensus. The process continued until the termination criteria were met. Two rounds were conducted. In round 1, 8 experts provided 7 revision suggestions; in round 2, 2 experts provided 3 suggestions. Each suggestion was accepted, adapted, or rejected, with the reason recorded (Section 3.4). These stopping criteria follow the Delphi practice conventional in Chinese nursing and rehabilitation research. The third criterion is a criterion about the experts rather than about the ratings: as prespecified, it asks whether at least 80% of experts report no further revisions or supplementary opinions, and it was applied and recorded at the level of the consultation round, where it governed whether a further round was required. In round 1, 8 of the 12 experts who responded entered at least one comment, so only 4 of 12 (33.3%) had nothing further to add, and the criterion was not met, which is why a second round was conducted; in round 2, 2 of the 11 experts who responded entered a comment, so 9 of 11 (81.8%) had nothing further to add, the criterion was met, and the consultation was closed. We did not verify the third criterion for each item separately. The retained records establish how many experts entered a comment in each round, but they do not allow every comment to be attributed both to the expert who wrote it and to the item it concerned with the confidence a reported count requires, and we judged it inappropriate to reconstruct that attribution now, after the panel had closed and the programme had been finalised: a consensus statistic produced by a later coding exercise would report our re-analysis rather than what the panel in fact did. The third criterion is therefore reported at the level at which it was applied and recorded—the consultation round—and we do not claim that it was met by any individual item. Two consequences follow, and we state both explicitly rather than leaving them to be inferred. First, the absence of a comment is an imperfect proxy for agreement, so the criterion is interpreted together with the mean score and the coefficient of variation and is not presented as more than it is. Second, we do not claim that every component of the final programme satisfied every predefined consensus criterion: the first two criteria are demonstrated rating by rating for all 30 round-2 item-by-dimension ratings, whereas the third rests on round-level evidence alone, and convergence in the ratings given to individual items together with closure of the consultation does not by itself establish that each component met it. In future Delphi consultations conducted to develop interventions of this kind, we will prespecify the item-level recording of every consensus criterion by linking each comment field to an anonymised expert identifier and entering the item-level status while the panel is still in session. Experts rated each item on two dimensions using a 5-point Likert scale: perceived methodological appropriateness (termed “scientificness” in the Chinese Delphi tradition, i.e., the extent to which an item is judged methodologically sound and consistent with current evidence and guidance) and perceived feasibility. These ratings represent structured expert judgement and do not constitute evidence of clinical or scientific validity. No item was deleted in either round. All 30 item-by-dimension ratings obtained in round 2 (15 items rated on two dimensions) satisfied the first two predefined criteria when each rating was checked individually rather than in aggregate: the lowest mean score was 3.91 (appropriateness of intervention duration) against a threshold of 3.5, and the highest coefficient of variation was 0.21 (appropriateness of the pressure variation protocol) against a threshold of 0.25. Items with a coefficient of variation above 0.25 after round 1 were revised in response to expert comment rather than removed, and all coefficients of variation fell below 0.25 in round 2. An item-by-item record of the mean and the coefficient of variation of each of the 30 round-2 ratings, their status against the first two criteria, and the decision taken for each of the 15 items is provided in Supplementary Table S1. The third criterion is an imperfect indicator of agreement; we therefore interpret it together with the mean score and the coefficient of variation rather than on its own, and, for the reason given above, it is reported at the level of the consultation round alone. Supplementary Table S1 accordingly records the status of each round-2 rating against the first two criteria and gives no item-level status for the third. No percentage of experts rating each item 4 or 5 is reported: that breakdown depends on the individual returned questionnaires and is not available.

2.2. Statistical Analysis

Data were analysed with IBM SPSS Statistics 23.0. (1) Expert characteristics: Categorical variables were described with frequency and percentage, presented as n (%). (2) Expert response rate: This is the proportion of valid questionnaires returned. (3) Expert authority: This was determined by the judgement basis and its influencing coefficient (Ca), as well as the experts’ familiarity coefficient with the consultation content (Cs). The arithmetic mean of the two values was calculated as the expert authority coefficient (Cr). Cr ranges from 0 to 1, and a value > 0.8 is generally regarded as acceptable. A higher Cr indicates a higher level of self-rated expert authority; it does not measure the predictive accuracy of the opinions expressed. (4) Concentration of expert opinions: This is presented as the mean ± standard deviation ( x ¯ ± s). (5) Coordination of expert opinions: This is described by the CV of each indicator and Kendall’s concordance coefficient (Kendall’s W). A smaller CV suggests higher expert coordination; conventionally, CV < 0.25 for all indicators is required. Kendall’s W ranges from 0 to 1, with a larger value representing better coordination, and should not be interpreted as indicating strong agreement without considering the coefficient of variation. (6) Qualitative analysis: The experts’ suggestions were summarised descriptively. The two components of the authority coefficient were computed as follows: familiarity: Cs = (1/K) Σk [Σj (Mjk · wj)/M], where k indexes the K = 3 content domains (sarcopenia exercise theory, blood flow restriction theory, and blood flow restriction combined with aerobic exercise practice), wj is the preset familiarity weight (familiar 1.0, relatively familiar 0.8, neutral 0.6, relatively unfamiliar 0.4, and unfamiliar 0.2), Mjk is the number of experts choosing level j in domain k, and M is the number of experts returning that round; judgement basis: Ca = Σj (Mj · wj)/M, summed over the four judgement sources with preset weights for large, moderate, and small influence, respectively (theoretical analysis 0.3/0.2/0.1; practical experience 0.5/0.4/0.3; knowledge of the domestic and international literature 0.1/0.1/0.05; intuition 0.1/0.1/0.05); because these weights are themselves scaled so that they can sum to 1.0, Ca is not divided by the number of sources. The coefficient is then Cr = (Cs + Ca)/2. All weights were fixed in advance from published Delphi methodology [20,21,22,23] and were not estimated from the present data, and no expert’s ratings were weighted by his or her Cr value.

3. Results

3.1. Characteristics of the Expert Panel

Twelve experts from seven cities (Beijing, Shanghai, Qingdao, Nanjing, Chongqing, Nanchang, and Suzhou) took part in this Delphi consultation. Their mean age was 42.25 ± 7.03 years (range 33–57) and their mean professional experience 16.33 ± 6.02 years (range 10–30). Six experts were affiliated with tertiary grade-A hospitals and six with universities; nine held senior professional titles (five full senior and four associate senior), and three held intermediate titles. Educational attainment, professional titles, positions, and research fields are given in Table 1.
Table 1. Characteristics of the expert panel, n (%).

3.2. Response Rate and Authority Coefficient of the Experts

In each round, 12 questionnaires were distributed, and 12 and 11 valid questionnaires were returned, giving effective response rates of 100% and 91.7%. The authority coefficient (Cr) was 0.91 in round 1 (Table 2 and Table 3) and 0.94 in round 2 (Table 4 and Table 5).
Table 2. Familiarity of experts with the consultation content (first round), assignment (number of experts).
Table 3. Judgement basis of experts (first round), assignment (number of experts).
Table 4. Familiarity of experts with the consultation content (second round), assignment (number of experts).
Table 5. Judgement basis of experts (second round), assignment (number of experts).

3.3. Expert Consensus and Coordination

Kendall’s W across the two rounds increased from 0.088 (p = 0.379) in the first round to 0.310 (p < 0.001) in the second round. The coefficient of variation for ratings of perceived methodological appropriateness (scientificness) decreased from 0.28–0.38 in the first round to 0.06–0.18 in the second round and for feasibility from 0.26–0.37 to 0.06–0.18, indicating that opinions converged (Table 6). W = 0.310 represents a statistically significant but moderate improvement in concordance and should not be interpreted as a high level of agreement. Kendall’s W and the coefficient of variation index complementary but distinct aspects of consensus: W reflects concordance in the ranking of items across experts, whereas the coefficient of variation reflects the dispersion of the ratings assigned to a single item. The combination of a moderate W with low second-round coefficients of variation therefore indicates convergence on the rating of individual items together with only moderate consistency in their relative ordering. The third predefined criterion asks whether at least 80% of experts report no further revisions or supplementary opinions; it concerns the experts rather than the ratings and was applied at the level of the consultation round, as set out in Section 2.1.4: 4 out of 12 experts (33.3%) had nothing further to add in round 1, with 9 out of 11 (81.8%) in round 2. It was not verified item by item: the retained records do not allow every comment to be attributed both to the expert who wrote it and to the item it concerned, and we did not reconstruct that attribution retrospectively. No percentage of experts rating each item 4 or 5 is given for the same reason: that breakdown depends on the individual returned questionnaires and is not available. The first two predefined criteria were applied to the final programme rating by rating rather than in aggregate: in round 2, all 30 item-by-dimension ratings satisfied them, with every mean score above 3.5 (lowest 3.91, appropriateness of intervention duration) and every coefficient of variation below 0.25 (highest 0.21, appropriateness of the pressure variation protocol). Reporting the range of means and coefficients of variation across items does not by itself establish that every component satisfied every criterion because a range describes dispersion and not the position of each individual rating relative to the thresholds; the status of each round-2 rating against the first two criteria is therefore given in Supplementary Table S1 alongside the aggregate statistics reported here. The third criterion is reported at the level of the round only, so Table S1 records no item-level status for it; we therefore do not claim that every component of the final programme satisfied every predefined criterion, and the point is recorded as a limitation in Section 5.
Table 6. Level of expert consensus (mean ± SD).

3.4. Revisions Arising from the Expert Consultation

No item was deleted in either round of the consultation.
In the first round, eight experts made seven suggestions for revision. Aerobic exercise component: (1) Mode: The permitted locations for the stepper were broadened to include “a machine fixed in the rehabilitation room of the institution”. (2) Intensity: An objective measure of intensity was needed at the end of exercise, so “immediate post-exercise blood lactate measurement” was added. (3) Time: A total of 60 min of aerobic exercise per week was judged insufficient. The ACSM recommends that older adults accumulate 150 min of low- to moderate-intensity aerobic exercise per week; allowing for the reduced physical capacity of people with sarcopenia, the programme was set at a total of 120 min per week, delivered as “2 sessions a day, 20 min each session, with intervals of 10 min or longer between sessions”. The second exercise session should begin after the heart rate has recovered to the resting heart rate. The programme was also expanded to specify the duration of the warm-up and cool-down and how they should be performed. BFR component: (1) Mode: A vascular warm-up was considered necessary, so we added that “during warm-up exercises, the legs are bound with elastic BFR cuffs, and the cuff pressure is 75 mmHg”. (2) Device: The standard for cuff tightness needed to be clarified: “tight enough that the researcher’s index finger can be inserted under the cuff when it is not inflated and secured so that it does not slip down during exercise”. (3) Time: Deflating the cuff immediately at the end of exercise can cause ischaemia–reperfusion injury, so the instruction was changed to “deflate slowly after the end of exercise and return to the non-inflated state within 30 s”. (4) Cuff placement: Placing the cuff close to the groin impedes movement, and a standard for wearing it was needed. The wording was therefore changed to “the upper edge of the cuff is positioned as close to the groin as possible without hindering leg movement” and “the participant should wear thin, close-fitting trousers as much as possible, so that no wrinkles are formed under the cuff”.
In the second round, two experts proposed three modifications: (1) replace the stepper specified in the draft with a cycle ergometer; (2) measure limb occlusion pressure (LOP) with a dedicated device during the intervention; and (3) if exercising every other day proved too demanding, keep an interval of 48 h between sessions. The research team responded as follows: (1) The stepper used here is compact, portable, and inexpensive. It allows resistance adjustment, timing, and distance measurement, and exercise power can be calculated from resistance and distance, all comparable to a cycle ergometer. A cycle ergometer, however, has a bicycle-type saddle that becomes uncomfortable over longer sessions, and its higher seat position increases the risk of falls in older adults. With the stepper, participants sit on a chair about 46 cm high with armrests, which is safer. The stepper was therefore retained. (2) Taken together, our two preliminary studies showed that the elastic cuff restricts blood flow to a degree comparable to a cuff that permits LOP measurement while being more comfortable, with higher exercise completion, fewer general exercise responses, and a smaller cardiovascular response. Other studies have also reported favourable training effects with elastic cuffs, so the elastic cuff was retained. (3) Although the programme adds BFR, it remains principally aerobic. Training on alternate days already meets the frequency and intensity that the ACSM recommends for aerobic exercise in older adults, so the third proposal was not adopted.
After the preliminary work and two rounds of consultation, the BFR-AE programme was finalised. It comprises an adaptation period (the week before the intervention proper), an intervention period (transition phase, weeks 1–4; maintenance phase, weeks 5–12), and a follow-up period (weeks 13–24) (Table 7).
Table 7. Intervention programme of blood flow restriction combined with aerobic exercise (final draft).

4. Discussion

We developed a preliminary draft from the literature and our own earlier findings and settled the final programme through two rounds of Delphi consultation. Studies of exercise programme development usually build their first draft from a literature review, sometimes combined with meta-analysis; that route was not fully open to us because research on BFR began relatively late in China, and the key exercise elements of the programme could not be identified from the literature alone. We therefore fixed the intervention variables by combining studies of blood flow under different cuffs and pressures with our own exercise tests in older adults with sarcopenia across a range of devices and pressures, which made the protocol safer and more workable.

4.1. Content Validity and Expert-Perceived Feasibility of the Program

The programme was guided by the exercise recommendations of the ACSM and the AHA, which rest on a substantial evidence base. The programme consists of two core components: AE and BFRT. Research on AE is well established, so this part of the programme was comparatively straightforward to specify. Studies from around the world report substantial inconsistencies in BFRT parameters—cuff type, applied pressure, and training regimen among them—which makes programme development harder [25,26,27]. Some non-elastic BFR cuffs carry the risk of complete arterial occlusion, but this risk can be mitigated by clearly defining pressure levels based on measured LOP. Elastic cuffs remove the risk of complete arterial occlusion, have a better safety profile, and are better tolerated; their main limitation is that LOP cannot be measured with them [28].
Against this background, we examined how blood flow changed with the two cuff types at different pressures: flow fell significantly in both and was negatively correlated with the applied pressure. For older adults with sarcopenia, training with a non-elastic cuff at 40–60% LOP and with an elastic cuff at 150–250 mmHg may therefore produce comparable effects. We also ran BFR-AE with different cuffs and pressures in the 31 older adults who completed all exercise testing, monitoring completion rates, cardiovascular responses, and adverse events. BFR-AE proved safe and highly feasible in this population [17]. Specifically, an elastic cuff inflated to 250 mmHg, with stepping resistance rising from level 2 to level 4 during adaptation and from level 4 to level 5 during the intervention, suited this population best. Within the conditions of this developmental study, the elastic cuff was better tolerated and achieved a higher completion rate at matched interface pressure. These findings justify the choice of the elastic cuff for this protocol; they do not establish the universal superiority of elastic over non-elastic BFR systems in older adults.
Based on the above findings, a preliminary draft of the BFR-AE programme was developed. We then used the Delphi method to canvass experts in BFR training from several regions, including Beijing and Shanghai. The two rounds of consultation yielded high expert response rates and authority coefficients, and Kendall’s coefficient of concordance in the second round was higher than that in the first round. This indicates that the opinion on all items converged over the two rounds. Furthermore, the perceived methodological appropriateness (scientificness) and feasibility scores, as well as the coefficients of variation, for all specific measures in the exercise programme met the two prespecified rating criteria—mean score >3.5 and CV <0.25—when each of the 30 round-2 ratings was checked individually. The programme finalised through consultation therefore has satisfactory content validity and was judged feasible by the panel. These findings do not establish clinical efficacy or definitive safety: expert consensus supports content validity and perceived feasibility, and the programme should not be described as validated or clinically effective. A definitive test of the additive effect of BFR requires a randomised comparison of BFR-AE against aerobic exercise alone with the aerobic workload matched as closely as possible; the present developmental study was not designed for this purpose and provides no evidence of additive benefit.

4.2. The Programme as a Reference for BFRT Intervention in Older Adults with Sarcopenia

Exercise improves several dimensions of physical fitness in older adults with sarcopenia, but their low baseline fitness limits exercise capacity, and moderate-intensity exercise is often beyond them. Finding combined interventions that produce worthwhile adaptations at lower intensities therefore matters a great deal for their rehabilitation.
BFRT is one such option, and it is most often combined with RE or AE [29]. BFR-RE increases the strength, cross-sectional area, and muscle mass of the targeted limbs within a short period and limits atrophy [30]. Compared with RE, AE is simpler to deliver, produces milder cardiovascular responses, and is more acceptable to older adults [31].
To date, multiple meta-analyses have confirmed that exercise combined with blood flow restriction produces beneficial outcomes in specific patient populations and athletes [7,32,33]. In sarcopenia, however, the optimal BFR parameters—degree of restriction, cuff type, and applied pressure—remain unclear and need further investigation. Meanwhile, high-quality research on the safety and efficacy of BFR-AE interventions is still lacking. If this combination improves cardiopulmonary function and muscular fitness at the same time, it can offer a non-pharmacological way of preventing the onset of sarcopenia and slowing its progression.
Rehabilitation nursing is becoming more specialised and its tasks more professional. Physical function and fitness have long been central concerns of rehabilitation nursing: improving them increases patients’ mobility and helps to prevent chronic disease and improve prognosis. For nurses, being able to deliver non-pharmacological interventions that improve physical function is therefore essential.

4.3. Levels of Evidence Supporting the Final Programme Parameters

To make the evidential status of each element explicit, the parameters of the final programme are classified into three levels. (a) Parameters supported by previous empirical evidence: These are the FITT-VP structure of the aerobic component, derived from ACSM/AHA and WHO guidance; seated stepping as the exercise mode, selected because more than 35% of the target population required a walking aid and seated exercise reduces fall risk; proximal-thigh cuff placement; and 3 min warm-up and cool-down. (b) Parameters supported by our own preliminary studies: These include the choice of the elastic cuff, which showed a higher completion rate and fewer general exercise responses at matched interface pressure; the 150/200/250 mmHg progression, whose haemodynamic effects fell within the range produced by 40–60% LOP with a non-elastic cuff, noting that this comparison was made under resting conditions and therefore constitutes indirect evidence; and individualisation of stepping resistance by target heart rate and RPE. (c) Parameters determined by expert consensus because the evidence was insufficient: These constitute the 4-week transition and 8-week maintenance phases, the total volume of 120 min/week, the structure of two 20 min sessions per day with an interval of ≥10 min, the 75 mmHg cuff pressure during warm-up, slow deflation over 30 s, the cuff-tightness standard, and the use of a single fixed pressure of 250 mmHg rather than a pressure individualised to measured limb occlusion pressure. Parameters in the third group should not be treated as evidence-based merely because they emerged from the Delphi procedure.

4.4. Rationale for the Dose and Progression of the Program

The total volume of 120 min/week is an intentional reduction from the 150–300 min/week of moderate-intensity aerobic activity recommended by the WHO in 2020 for adults aged ≥65 years. This reduction is an investigator adaptation rather than a guideline recommendation: our target population is frail, frequently multimorbid, and previously sedentary, and in such populations, any increase in activity confers benefit. Two 20 min bouts were preferred to a single 40 min bout because blood flow restriction exercise bouts are conventionally limited to ≤30 min. Three sessions per week on alternate days were selected; the experts’ proposal of a 48 h interval was not adopted because training on alternate days already provides an interval of ≥48 h between sessions. The 4-week transition phase reflects ACSM guidance that intensity can be progressively increased over the first 4–6 weeks together with exercise adaptation theory; the 8-week maintenance phase (weeks 5–12) reflects meta-analytic evidence that at least 12 weeks is required to improve body composition and muscle strength in older adults with sarcopenia. Intensity was individualised by titrating stepping resistance session by session: 30–39% of heart rate reserve (or RPE 10–11) defined low intensity, and 40–59% (or RPE 12–13) defined moderate intensity, with resistance adjusted up or down according to prespecified rules. We note explicitly which elements are guidance-derived and which are investigator adaptations, and we do not present the latter as though the ACSM recommended them. Several of these choices—the weekly volume, the split-session structure, the length of the transition and maintenance phases, the warm-up cuff pressure, and the use of a fixed rather than an individualised cuff pressure—are ultimately pragmatic decisions supported by indirect evidence, and we present them as such rather than as physiologically optimal prescriptions.
This study has several limitations. First, the programme was developed through an evidence-informed narrative literature review, preliminary exploratory testing, and Delphi expert consensus rather than a clinical efficacy trial. Therefore, the perceived methodological appropriateness (scientificness) and feasibility reported here refer to content validity and expert-perceived feasibility, not to proven clinical effectiveness. Second, the safety data come from a small exploratory sample of 31 participants exercising under supervision; they cannot be generalised to unsupervised or home-based BFR-AE. Third, the Delphi panel included 12 experts, and although the response and authority coefficients were high, expert opinion may still be influenced by professional background. Fourth, the optimal BFR pressure may vary with cuff type, cuff width, limb circumference, and individual LOP; the 250 mmHg protocol used here is specific to the elastic cuff and the studied population, and because the pressure is fixed rather than individualised, it cannot accommodate this variation, a limitation that is likely to be amplified in sarcopenia, where limb muscle mass and composition differ from those of the general older population. The concern is not merely theoretical: limb circumference is the strongest single predictor of the pressure required to occlude arterial flow in the lower limb [34], and in the upper limb at sub-occlusive pressures (20–60 mmHg), the proportion of muscle in the limb accounts for more of the between-individual variation in the restriction achieved than circumference does [35]. A single fixed pressure cannot therefore be expected to produce the same restriction in every participant, and the discrepancy is likely to be larger in a population in which limb composition is altered. Future randomised controlled trials with larger samples, blinding where possible, and long-term follow-up are needed to confirm efficacy, safety, adherence, and generalisability. Fifth, the Delphi panel did not include specialists in vascular medicine, geriatric medicine, cardiology, or clinical exercise physiology; because the protocol involves vascular restriction in an older clinical population, this limits the breadth of the safety perspective and should be addressed in future consensus exercises. Sixth, the equivalence between the elastic and non-elastic cuffs was established under resting conditions, and extrapolation to exercising muscle is approximate. Seventh, the literature review was an evidence-informed narrative review rather than a registered systematic review, and no PRISMA flow diagram was produced. Eighth, the predefined consensus criteria could not be applied to the final programme with the same rigour at every level. The mean-score and coefficient-of-variation criteria were checked rating by rating, and all 30 round-2 item-by-dimension ratings met them; the third criterion—that at least 80% of experts report no further revisions or supplementary opinions—was applied and recorded at the level of the consultation round (33.3% in round 1 and 81.8% in round 2), and the retained records do not permit it to be verified for each item separately. We therefore do not claim that every component of the final programme satisfied every predefined consensus criterion, and we regard the absence of an item-level record of the stopping criteria as a weakness of the design of this consultation rather than as a property of the programme. Two consequences follow for our subsequent work. In future Delphi studies, we will prespecify the item-level recording of every consensus criterion, linking each comment field to an anonymised expert identifier and entering the item-level status while the panel is still in session. The programme itself will be revisited after the randomised controlled trial registered as ChiCTR2200064080, when the parameters that currently rest on consensus alone (Section 4.3 (c)) can be re-examined against trial data on feasibility, adherence, and safety.
Finally, the pressure used in this protocol is fixed rather than individualised. The relation between cuff pressure, limb circumference, and the resulting reduction in arterial inflow is unlikely to be linear and is likely to vary between individuals; formalising it as a dynamic system that can be solved semi-analytically [36] is one possible route to individualised pressure prescription; we regard it as a direction for future work rather than a property of the present protocol. We therefore distinguish what was observed—that this pressure was tolerated under supervision and reduced resting blood flow to a comparable degree—from what was assumed, namely that the resting comparison extrapolates to exercising muscle and that one fixed pressure is suitable for all participants in this population.

5. Conclusions

This study developed a BFR-AE programme for older adults with sarcopenia through an evidence-informed narrative review, exploratory exercise testing in 31 participants, and two rounds of Delphi consultation. The programme has satisfactory content validity and was judged feasible by the panel, and it provides a structured protocol for subsequent feasibility and efficacy testing. Its parameters rest on three different kinds of support—published evidence, our own exploratory data, and, where evidence was lacking, expert consensus—and those resting on consensus should not be read as evidence-based. Clinical efficacy and definitive safety remain to be established in adequately powered randomised controlled trials.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jgg74040047/s1. Table S1. Item-by-item ratings, status against the first two predefined consensus criteria, and decision taken for each item. Table S2. Complete literature search strategy.

Author Contributions

Conceptualisation, Y.L., L.W. and H.Z.; methodology, Y.L., S.Y., R.M. and K.S.; literature search and data extraction, R.M., J.C. and Y.M.; exploratory exercise testing, Y.L., S.Y. and K.S.; Delphi consultation organisation, Y.L., S.Y. and H.Z.; formal analysis, R.M., J.C. and Y.M.; investigation, Y.L., S.Y., R.M., J.C., Y.M. and K.S.; data curation, R.M., J.C. and Y.M.; writing—original draft preparation, Y.L.; writing—review and editing, all authors; supervision, L.W. and H.Z.; project administration, Y.L. and H.Z.; funding acquisition, H.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the GuSu Health Talent Program Research Project (GSWS2025104) and the Doctoral Research Start-up Grant Program of Suzhou Vocational Health College (SZWZYQDJ2501). The funders covered research personnel costs and expert honoraria.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Soochow University (Approval No. SUDA20220723H01; approval date: 23 July 2022). The Delphi expert consultation formed part of the same approved protocol, which and was reviewed and approved by that committee under the same approval number (SUDA20220723H01); it involved only expert professional judgement and no collection of biological specimens or identifiable health data. The project was registered with the Chinese Clinical Trial Registry (Registration No. ChiCTR2200064080).

Data Availability Statement

The data underlying this article will be shared upon reasonable request to the corresponding author.

Acknowledgments

We thank all participants and the Delphi experts for their time and effort.

Conflicts of Interest

Shengjie Yu is employed by Age-Wise Care (Suzhou) Intelligent Technology Co., Ltd. This company had no role in the study design, data collection, analysis, interpretation, manuscript writing, or decision to publish. The other authors declare no competing interests. The BFR cuffs and the stepper used in this study are commercially available products; no commercial company provided financial or material support for this study or influenced the study design or interpretation.

References

  1. Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48, 16–31. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Chen, L.-K.; Woo, J.; Assantachai, P.; Auyeung, T.-W.; Chou, M.-Y.; Iijima, K.; Jang, H.C.; Kang, L.; Kim, M.; Kim, S.; et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J. Am. Med. Dir. Assoc. 2020, 21, 300–307.e302. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Petermann-Rocha, F.; Balntzi, V.; Gray, S.R.; Lara, J.; Ho, F.K.; Pell, J.P.; Celis-Morales, C. Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle 2022, 13, 86–99. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Nelson, M.E.; Rejeski, W.J.; Blair, S.N.; Duncan, P.W.; Judge, J.O.; King, A.C.; Macera, C.A.; Castaneda-Sceppa, C. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Med. Sci. Sports Exerc. 2007, 39, 1435–1445. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Corrêa, H.L.; Neves, R.V.P.; Deus, L.A.; Souza, M.K.; Haro, A.S.; Costa, F.; Silva, V.L.; Santos, C.A.R.; Moraes, M.R.; Simões, H.G.; et al. Blood Flow Restriction Training Blunts Chronic Kidney Disease Progression in Humans. Med. Sci. Sports Exerc. 2021, 53, 249–257. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Cuffe, M.; Novak, J.; Saithna, A.; Strohmeyer, H.S.; Slaven, E. Current Trends in Blood Flow Restriction. Front. Physiol. 2022, 13, 882472. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Wortman, R.J.; Brown, S.M.; Savage-Elliott, I.; Finley, Z.J.; Mulcahey, M.K. Blood Flow Restriction Training for Athletes: A Systematic Review. Am. J. Sports Med. 2021, 49, 1938–1944. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Staunton, C.A.; May, A.K.; Brandner, C.R.; Warmington, S.A. Haemodynamics of aerobic and resistance blood flow restriction exercise in young and older adults. Eur. J. Appl. Physiol. 2015, 115, 2293–2302. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  9. Clarkson, M.J.; Conway, L.; Warmington, S.A. Blood flow restriction walking and physical function in older adults: A randomized control trial. J. Sci. Med. Sport 2017, 20, 1041–1046. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Zhang, M.; Song, Y.; Zhu, J.; Ding, P.; Chen, N. Effectiveness of low-load resistance training with blood flow restriction vs. conventional high-intensity resistance training in older people diagnosed with sarcopenia: A randomized controlled trial. Sci. Rep. 2024, 14, 28427. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Li, W.; Hu, M.; Yin, Q.; Liu, Y.; Chen, L.; Ru, Q.; Xu, G.; Wu, Y. Blood flow restriction training: A new approach for preventing and treating sarcopenia in older adults. Front. Physiol. 2025, 16, 1616874. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Xiang, Q.; Hu, Y.; Zheng, J.; Liu, W.; Tao, J. Research hotspots and trends of exercise for sarcopenia: A bibliometric analysis. Front. Public Health 2023, 11, 1106458. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Yuan, J.; Wu, L.; Xue, Z.; Xu, G.; Wu, Y. Application and progress of blood flow restriction training in improving muscle mass and strength in the elderly. Front. Physiol. 2023, 14, 1155314. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Citherlet, T.; Willis, S.J.; Chaperon, A.; Millet, G.P. Differences in the limb blood flow between two types of blood flow restriction cuffs: A pilot study. Front. Physiol. 2022, 13, 931270. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Zhang, H.; Li, M.; Mao, Z.; Yin, T.; Qi, J.; Wang, F.; Wang, L. Effects of Blood Flow Restriction Combined with Aerobic Stepping Exercise in Sarcopenia: A Study Protocol for a Randomized Clinical Trial. Int. J. Gen. Med. 2024, 17, 6393–6405. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  16. Mezzani, A.; Agostoni, P.; Cohen-Solal, A.; Corrà, U.; Jegier, A.; Kouidi, E.; Mazic, S.; Meurin, P.; Piepoli, M.; Simon, A.; et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: A report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur. J. Cardiovasc. Prev. Rehabil. 2009, 16, 249–267. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. Zhang, H.; Liu, S.; Mao, Z.; Niu, K.; Li, X.; Yin, T.; Wang, F.; Wang, L. The Safety of Blood Flow Restriction Combined with Stepping Aerobic Exercise in Older Adults with Sarcopenia. Clin. Interv. Aging 2025, 20, 1165–1179. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  18. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription, 11th ed.; Wolters Kluwer: Philadelphia, PA, USA, 2022. [Google Scholar]
  19. Patterson, S.D.; Hughes, L.; Warmington, S.; Burr, J.; Scott, B.; Owens, J.; Abe, T.; Nielsen, J.; Libardi, C.A.; Laurentino, G.; et al. Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety. Front. Physiol. 2019, 10, 533. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  20. Mutisya, A.; Wagoro, M.; Nzengya, D.; Edwards, J.; Secor-Turner, M. Nursing and midwifery research priorities for Kenya: Results from a national Delphi survey. Int. Nurs. Rev. 2023, 70, 569–577. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  21. Liu, X.; Liu, L.; Zhang, J.; Meng, X.; Huang, C.; Zhang, M. Construction and evaluation of nursing-sensitive quality indicators for vaginal birth after cesarean: A Delphi study based on Chinese population. Heliyon 2023, 9, e21389. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Ding, Q. A system for preventing internal fistula needle dislodgement: Delphi study and pilot evaluation. Jpn. J. Nurs. Sci. 2023, 20, e12530. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  23. Ghosh, M.; Nosaka, K.; Whitehead, L.; Nosaka, K. Identifying key elements to assess patient’s acceptability of neurorehabilitation in stroke survivors—A Delphi method. Disabil. Rehabil. 2022, 44, 6258–6266. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. Humphrey-Murto, S.; Wood, T.J.; Gonsalves, C.; Mascioli, K.; Varpio, L. The Delphi Method. Acad. Med. 2020, 95, 168. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Zhang, X.-Z.; Xie, W.-Q.; Chen, L.; Xu, G.-D.; Wu, L.; Li, Y.-S.; Wu, Y.-X. Blood Flow Restriction Training for the Intervention of Sarcopenia: Current Stage and Future Perspective. Front. Med. 2022, 9, 894996. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  26. Yasuda, T. Selected Methods of Resistance Training for Prevention and Treatment of Sarcopenia. Cells 2022, 11, 1389. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Lim, Z.X.; Goh, J. Effects of blood flow restriction (BFR) with resistance exercise on musculoskeletal health in older adults: A narrative review. Eur. Rev. Aging Phys. Act. 2022, 19, 15. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  28. Stray-Gundersen, S.; Wooten, S.; Tanaka, H. Walking With Leg Blood Flow Restriction: Wide-Rigid Cuffs vs. Narrow-Elastic Bands. Front. Physiol. 2020, 11, 568. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  29. Lorenz, D.; Bailey, L.; Wilk, K.; Mangine, B.; Head, P.; Grindstaff, T.L.; Morrison, S. Blood Flow Restriction Training. J. Athl. Train. 2021, 56, 937–944. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Liu, Y.; Jiang, N.; Pang, F.; Chen, T. Resistance Training with Blood Flow Restriction on Vascular Function: A Meta-analysis. Int. J. Sports Med. 2021, 42, 577–587. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  31. Cahalin, L.P.; Formiga, M.F.; Anderson, B.; Cipriano, G.; Hernandez, E.D.; Owens, J.; Hughes, L. A call to action for blood flow restriction training in older adults with or susceptible to sarcopenia: A systematic review and meta-analysis. Front. Physiol. 2022, 13, 924614. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  32. Centner, C.; Lauber, B. A Systematic Review and Meta-Analysis on Neural Adaptations Following Blood Flow Restriction Training: What We Know and What We Don’t Know. Front. Physiol. 2020, 11, 887. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Nitzsche, N.; Stäuber, A.; Tiede, S.; Schulz, H. The effectiveness of blood-flow restricted resistance training in the musculoskeletal rehabilitation of patients with lower limb disorders: A systematic review and meta-analysis. Clin. Rehabil. 2021, 35, 1221–1234. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Loenneke, J.P.; Allen, K.M.; Mouser, J.G.; Thiebaud, R.S.; Kim, D.; Abe, T.; Bemben, M.G. Blood flow restriction in the upper and lower limbs is predicted by limb circumference and systolic blood pressure. Eur. J. Appl. Physiol. 2015, 115, 397–405. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  35. Meek, A.W.; Heavrin, A.M.; Mikesky, A.E.; Segal, N.A.; Riley, Z.A. Subject factors influencing blood flow restriction in the arm at low cuff pressures. Clin. Physiol. Funct. Imaging 2022, 42, 233–240. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  36. Nave, O. Modification of Semi-Analytical Method Applied System of ODE. Mod. Appl. Sci. 2020, 14, 75. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.